Research progress on prevention and treatment of central obesity
10.19485/j.cnki.issn2096-5087.2026.07.009
- Author:
TU Chuanfa
;
WANG Xinyi
;
ZHANG Youyou
;
ZHU Shuang
;
WU Shan
;
WANG Liangyou
- Publication Type:Journal Article
- Keywords:
central obesity;
pathogenesis;
diagnosis;
treatment
- From:
Journal of Preventive Medicine
2026;38(7):686-689
- CountryChina
- Language:Chinese
-
Abstract:
Abstract:Central obesity is characterized primarily by visceral fat accumulation, which increases the risk of metabolic complications and premature death. This study reviewed literature on central obesity published in databases such as PubMed and China National Knowledge Infrastructure from 2004 to 2024, reviewing advancements in its pathogenesis, diagnosis, and prevention/treatment. Regarding pathogenesis, abnormalities in epigenetic regulation, gut microbiota imbalance, dysfunction of the hypothalamic-pituitary-adrenal axis and the gut-brain axis contribute to abnormal visceral fat accumulation, leading to central obesity. In terms of diagnosis, the optimized application of the International Diabetes Federation's waist circumference criteria, along with Chinese indicators such as waist-to-hip ratio and waist-to-height ratio, enhances early identification and diagnostic accuracy. For prevention and treatment, lifestyle interventions including energy-restricted diets, intermittent fasting, and optimized exercise regimens combined with multidimensional strategies involving pharmacotherapy and bariatric surgery, can effectively improve central obesity. With advances in precision medicine and translational medicine, the management of central obesity is shifting from empirical medicine to precision medicine and from single-treatment approaches to comprehensive interventions, providing evidence-based foundations for refining strategies aimed at central obesity prevention and control.
- Full text:2026111209440922551中心性肥胖防治研究进展.pdf
